4.1.1.29	5,5'-dithiobis(2-nitrobenzoate)	-	303	
4.1.1.29	alpha-Methyl-DL-cysteine sulfinate	-	96128	
4.1.1.29	beta-DL-Homocysteine sulfonate	-	96218	
4.1.1.29	beta-Ethylidene-DL-aspartate	mechanism-based inhibitor	92753	
4.1.1.29	beta-Methyleneaspartate	potent irreversible	43863	
4.1.1.29	beta-Methyleneaspartate	mechanism-based	43863	
4.1.1.29	BH4-	-	45993	
4.1.1.29	Cu2+	-	19	
4.1.1.29	Cys	enzyme form CSAD II is inhibited, no effect on enzyme form CSAD I	553	
4.1.1.29	cysteic acid	inhibits decarboxylation of cysteine sulfinic acid	8078	
4.1.1.29	cysteic acid	-	8078	
4.1.1.29	cysteic acid	enzyme form CSAD II is inhibited, no effect on enzyme form CSAD I	8078	
4.1.1.29	cysteine	cysteine is able to enter the active site of the enzyme, interact with the pyridoxal 5'-phosphate-lysine internal aldimine, form a cysteine-pyridoxal 5'-phosphate aldimine and undergo intramolecular nucleophilic cyclization through its sulfhydryl group, leading to irreversible inactivation. Reaction is similar for aspartate decarboxylase, glutamate decarboxylase and cysteine sulfinic acid decarboxylase	153	
4.1.1.29	D-Cysteine sulfinate	-	43979	
4.1.1.29	DL-2-amino-3-phosphonopropionate	-	20713	
4.1.1.29	Glu	brain enzyme	343	
4.1.1.29	Glu	competitive with cysteic acid	343	
4.1.1.29	Hg2+	-	33	
4.1.1.29	Homocysteic acid	-	44230	
4.1.1.29	iodoacetamide	-	67	
4.1.1.29	iodoacetic acid	-	213	
4.1.1.29	L-Asp	-	294	
4.1.1.29	L-cysteine sulfinate	inhibits decarboxylation of cysteic acid	5564	
4.1.1.29	L-cysteine sulfonate	-	96686	
4.1.1.29	L-Homocysteine sulfonate	-	96693	
4.1.1.29	Met	inhibits enzyme form CSAD I and CSAD II	678	
4.1.1.29	NEM	-	89	
4.1.1.29	NO	fusion protein with beta-galactosidase	277	
4.1.1.29	noradrenaline	reversed by addition of 0.1 mM pyridoxal 5'-phosphate	2574	
4.1.1.29	O2	fusion protein with beta-galactosidase	9	
4.1.1.29	p-hydroxymercuribenzoate	-	98	
4.1.1.29	Penicillamine	reversed by addition of 0.1 mM pyridoxal 5'-phosphate	2496	
4.1.1.29	Zn2+	-	14